Physician profile
John L Eakin
NPI 1316239775
$38,469.24
in general payments reported to CMS, 2019-2025
12 companies · $5,154 in 2025
The $5,154 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.81 · 2020: $3,149 · 2021: $1,200 · 2022: $1,615 · 2023: $23K · 2024: $4,301 · 2025: $5,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $7,782 · Food and Beverage: $4,612 · Education: $80.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $7,781.95 |
| Food and Beverage | $4,611.71 |
| Education | $80.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,289.24 | 2023-2025 | |
| Smith+Nephew, INC. | $6,456.67 | 2022-2025 | Evos, Novostitch, Trigen |
| Pylant Medical | $5,669.16 | 2020-2022 | |
| Stryker Corporation | $3,067.47 | 2022-2025 | Mako, Insignia, Blueprint Patient Specific Instrumentation |
| Alliance Medical | $310.16 | 2024-2025 | |
| Sawtooth Surgical Solutions INC | $182.53 | 2024 | |
| Nuvasive Specialized Orthopedics, INC. | $178.68 | 2023 | Precice Intramedullary Limb Lengthening System |
| Evolution Surgical, INC | $89.13 | 2023-2024 | |
| Orthofix Medical, INC. | $73.99 | 2023 | Trinity Elite |
| Vericel Corporation | $72.33 | 2024 | Maci |
| Karl Storz Endoscopy-America | $49.07 | 2023 | |
| Medtronic USA, INC. | $30.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Eakin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.